Frequently Asked Questions

Is Glypican-1 a Good Target for Radiotherapy?

Glypican-1 (GPC-1) is a cell surface proteoglycan overexpressed in multiple solid tumours, including bladder, breast, cervical, and pancreatic cancers.

Its overexpression is associated with poor prognosis and tumour growth.

GPC-1 acts as a co-receptor for various growth factors, regulating multiple cellular signalling pathways and promoting tumorigenesis.

Read more about it.